Big Move For Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. (PHAT:NASDAQ) jumped higher at $8.92, representing a gain of 90.2%. On Fri, Jun 06, 2025, PHAT:NASDAQ touched a New 2-Week High of $8.92. The stock appeared on our News Catalysts scanner on Fri, Jun 06, 2025 at 02:42 PM in the 'BIOTECH' category. From Fri, May 23, 2025, the stock recorded 55.56% Up Days and 70.00% Green Days

The stock spiked on Fri, Jun 06, 2025 at $12.32 with a volume of 52M+.

About Phathom Pharmaceuticals, Inc. (PHAT:NASDAQ)

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprise of vonoprazan, an oral small molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.